Poster at the AACR Liver Conference

20 May, 2022

LMU participated in the Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer organized by the American Association for Cancer Research. They presented their latest results on the in silico drug repurposing of mebendazole as a treatment option for chemoresistant hepatoblastoma.